You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      3rd Line Therapy or More to Treat Adult CML- CP in Real World

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Asciminib
      • (no location specified)
      Oct 16, 2023

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Jena, Germany
        Universitätsklinikum Jena
      Jan 17, 2023

      Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

      Completed
      • Leukemia
      • No Intervention
      • Cambridge, Massachusetts
        Takeda
      Feb 28, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Dasatinib Pill
        • Ketoconazole Pill
        • Monterrey, Nuevo Leon, Mexico
          Hospital Universitario Dr. José Eleuterio González
        Nov 25, 2022

        According to Molecular Identification at Diagnosis

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Next Generation Sequencing (DNA and RNA)
        • (no location specified)
        Oct 28, 2022

        Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

        Not yet recruiting
        • Tyrosine Kinase Inhibitors
        • Chronic Myeloid Leukemia
        • treatment of TKI in CML
        • Poitiers, France
          Chu Poitiers
        Feb 21, 2023

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 24, 2022

        Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

        Recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • Recombinant Interleukin-7
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 26, 2023

        Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

        Active, not recruiting
        • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 2, 2022

        Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

        Completed
        • Leukemia, Myelogenous, Chronic
        • CTTQ Dasatinib tablet
        • Sprycel Dasatinib tablet
        • Changchun, Jilin, China
          Affiliated Hospital of Changchun University of Traditional Chine
        Dec 7, 2022

        Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

        Not yet recruiting
        • Chronic Myeloid Leukemia, BCR/ABL-Positive
          • Taipei, Taiwan
            National Taiwan University Hospital
          Jul 24, 2022

          Chronic Myeloid Leukemia Trial (Asciminib)

          Available
          • Chronic Myeloid Leukemia
          • (no location specified)
          Jan 17, 2023

          Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

          Recruiting
          • Myeloproliferative Neoplasm
          • +2 more
          • Online Mindfulness Meditation
          • Internet-Based Webinars
          • San Francisco, California
            University of California San Francisco
          Aug 9, 2022